ASPET

American Society for Pharmacology & Experimental Therapeutics: Our members conduct research that develops disease-fighting medicines and therapeutic agents.

[ASPET @ASPET]

Did you attend the ASPET 2026 Annual Meeting? Relive your experiences, or learned what you missed, in the new issue of The Pharmacologist: https://t.co/woipNGyvLP

[ASPET @ASPET]

📅 TODAY, 2 pm ET: Join ASPET's Government Affairs Staff for an informal office hour about the proposed OMB rule. Whether you have questions about the rule itself, its implications, or how you can submit comments, please join us! Register: https://t.co/rnwkYtv5UB

[ASPET @ASPET]

ASPET welcomes Dr. Kathryn Meier, PhD, FASPET as ASPET President, as well as all our volunteer leaders who begin their term today with the Society. We appreciate your time and service and look forward to working with you to advance ASPET’s mission.

[ASPET @ASPET]

Have you submitted your research to ASPET Discovery? This Gold Open Access journal covers a variety of areas in pharmacology, and its diverse editorial board ensures the presentation of rigorous, sound science: https://t.co/QZBEtaksDX

[ASPET @ASPET]

Join ASPET for a free webinar designed for students interested in gaining a PhD degree in pharmacology and physiology. Our webinar will provide an overview of the graduate program at @UTHealthSA. Register: https://t.co/S1QjslMbh4

[ASPET @ASPET]

The current ASPET volunteer leadership terms end today, June 30th. We thank all of our volunteer leaders who generously dedicate their time and expertise to the Society. In particular, ASPET is grateful to Dr. Randy Hall for his service as President.

[ASPET @ASPET]

📅 Wed., July 1, 2 pm ET: Join ASPET's Government Affairs Staff for an informal office hour about the proposed OMB rule. Whether you have questions about the rule itself, its implications, or how you can submit comments, please join us! Register: https://t.co/rnwkYtv5UB

[ASPET @ASPET]

Read JPET's recent Editor's Choice, which gives hope that a novel treatment may come to fruition to help our endogenous T cells target cancer: https://t.co/rwbvCmDSkc

[ASPET @ASPET]

Hear from two dynamic young scientists studying molecular mechanisms that impact metabolism and liver disease, and learn about their novel approaches.

This free webinar is open to both members and non-members, and in partnership with AMSPC. Sign up: https://t.co/kyHqkto6Kc

[ASPET @ASPET]

Be on the cover of an ASPET journal!

We're seeking original artwork for ASPET's five journals. Your artwork will be displayed for a full year, and each winning image will receive a cash prize. Learn more! https://t.co/MIQnTQqlf4

[ASPET @ASPET]

🚨🚨 Calling ALL scientists: We need YOU to submit comments on the Office of Management and Budget (OMB) proposed rule which, if implemented, would make drastic changes to the current federal grantmaking process. Draft and submit your comment here: https://t.co/A7BdFqZsLH

[ASPET @ASPET]

Keiichiro Nakamura, a PhD student, is the Drug Metabolism and Disposition HTA for June 2026. His research focuses on developing human-relevant experimental models to better understand how drugs are absorbed in the intestine: https://t.co/Ta4MEo1de9

[ASPET @ASPET]

Interested in learning how your organization can best advocate for science policy? ASPET’s Government Affairs and Science Policy provides on-hands guidance on how your voice can be heard!

Learn more and take advantage of this opportunity: https://t.co/KGo9xFbywd

[ASPET @ASPET]

🚨 There’s one week left to apply for the ASPET Washington Fellows Program!

If you are a grad student, postdoc, or early career investigator, and are interested in science policy and advocacy, then this program is for you.
https://t.co/qA9l7zsuKV

[ASPET @ASPET]

Thomas Burris, PhD, and winner of the 2026 Goodman and Gilman Award, presents “Drugging Time: Nuclear Receptors and the Pharmacological Control of Circadian Physiology.” Join us for this special presentation, open to both ASPET members and non-members: https://t.co/C2ZOxbvpvs

[ASPET @ASPET]

Make sure to submit your research to our upcoming collection in Molecular Pharmacology! Submissions due August 31. Learn more: https://t.co/YSsGFTX1J9

[ASPET @ASPET]

Our most recent Featured Article in JPET, which offers a possible therapeutic strategy for Alzheimer's disease, is free-to-read for a limited time. Check out the research and share it with your colleagues: https://t.co/vt4r77KMXM

[ASPET @ASPET]

Erica Levitt, PhD, PharmD, and winner of the 2026 John J. Abel Award, presents “Understanding Opioid Overdose: One Breath at a Time.” This special presentation is open to both ASPET members and non-members. Learn more and register: https://t.co/Z26jAdjMzU

[ASPET @ASPET]

Ben Clements, PhD, a Postdoctoral Research Fellow, is the JPET HTA for June 2026. His research focuses on the characterization of novel pain therapeutics, ranging from NMDA receptor antagonists to opioid receptor allosteric modulators.

🔗 https://t.co/r05WkJBGio

[ASPET @ASPET]

The data in JPET's recent Editor's Choice suggests inhibitors that target the SOX11 DNA-binding domain may be effective in neuroendocrine prostate cancer, providing hope that the most aggressive prostate cancer can be treated. Read the research: https://t.co/AwTcH4Pcaz